Technology Training - Click Here!

$6M for Intercellular Bio-agent Countermeasures

Related Stories: Americas - USA, Biological Weapons, Medical, R&D - Contracted, Small Business, WMD Defenses

Advertisement
WMD_Nuclear_BioHazard.jpg

Genetic Chemistry, Inc. in Palo Alto, CA received a $6 million cost-plus-fixed-fee contract for “research to develop countermeasures to an intercellular bio threat agent.”

Work will be performed in Palo Alto, CA and is expected to be complete by July 28/11. Multiple bids were solicited in October 2006, and 1 bid was received by the Research, Development & Engineering Command Acquisition Center in Research Triangle Park, NC (W911NF-08-C-0023).

Images on Defense Industry Daily

Defense Industry Daily does not own the rights to the images displayed on our site. We use images under "fair use" copyright doctrine, from public sources and private organizations, or use images under Creative Commons/ GNU licenses that make them available to the general public, or with explicit and noted permission. All rights remain with the original image owners.

If you believe that a DID image may violate these conditions, please discuss it with us via an email to editorial@defenseindustrydaily.com

The sizes displayed on DID are the only sizes we have to offer.


Close